A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal

Details for Australian Patent Application No. 2004237153 (hide)

Owner Pfizer Products Inc.

Inventors Sands, Steven B.; Iredale, Philip A.; Coe, Jotham W.

Agent Shelston IP

Pub. Number AU-A-2004237153

PCT Pub. Number WO2004/098580

Priority 60/469,429 09.05.03 US

Filing date 5 May 2004

Wipo publication date 18 November 2004

International Classifications

A61K 031/00

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/098580 Priority application(s): WO2004/098580

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237155-Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals

2004237134-Sterilisation device